Form 4: Monopar Therapeutics CEO Reports Stock Transaction
Insider Transaction (Form 4)
Chandler Robinson, Chief Executive Officer and a Director of Monopar Therapeutics, reported multiple transactions in common stock on September 30, 2026.
Summary
- Option exercise/conversion: acquired 9,801 Common Stock on September 30, 2026; holds 109,068 after (Direct).
- Tax/exercise-price withholding: disposed of 4,344 Common Stock at $79.67 ($346,086) on September 30, 2026; holds 104,724 after (Direct).
- Option exercise/conversion: disposed of 9,801 Restricted Stock Unit on September 30, 2026; holds 83,602 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Chandler Robinson — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Option exercise/conversion | Common Stock | 9,801 | — | — | 109,068 |
| 2026-09-30 | Tax/exercise-price withholding | Common Stock | 4,344 | $80 | $346.1K | 104,724 |
| 2026-09-30 | Option exercise/conversion | Restricted Stock Unit | 9,801 | — | — | 83,602 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Option exercise/conversion (9,801 shares) |
| 2026-09-30 | Tax/exercise-price withholding (4,344 shares) |
| 2026-09-30 | Option exercise/conversion (9,801 shares) |
Keywords
insider transaction, Form 4, MNPR, Monopar Therapeutics, neutral, Chandler Robinson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.